(Adds analyst, banker comments, companies declining explanations). By Caroline Humer and Ransdell Pierson. Oct 22 (Reuters) - Drugmakers Abbott Laboratories and Mylan Inc on Wednesday declined to explain in detail why they changed the terms of a ...
Mylan, Abbott to proceed with merger
New tax rules won't spook Mylan out of Abbott generics buy
Related articles »